703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition

• Jose Lutzky,
• Anthony Cruz,
• Satu Mustjoki,
• James Dollar,
• Christina Decatur,
• Michael Durante,
• Jani Huuhtanen,
• Zelia Correa,
• J William Harbour

Affiliations

Jose Lutzky

5University of Miami Sylvester Cancer Center, Miami, FL, USA

Anthony Cruz

Aff4 grid.94365.3d0000000122975165National Institute of Arthritis and Musculoskeletal and Skin DiseasesNIH Bethesda MD USA

Satu Mustjoki

TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Uusimaa, Finland

James Dollar

1University of Miami School of Medicine, Miami, FL, USA

Christina Decatur

1University of Miami School of Medicine, Miami, FL, USA

Michael Durante

1University of Miami School of Medicine, Miami, FL, USA

Jani Huuhtanen

2University of Helsinki, Helsinki, Finland

Zelia Correa

1University of Miami School of Medicine, Miami, FL, USA

J William Harbour

3University of Texas Southwestern Medical Center, Dallas, TX, USA